Monday, April 27, 2009 2:58:08 PM
What's all this on seeking alpha about a takeover rumor?
Recent BMRN News
- BioMarin Announces Board Leadership Transition • PR Newswire (US) • 04/21/2026 08:23:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/21/2026 08:22:50 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2026 08:21:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/21/2026 08:19:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:53:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:50:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:48:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:34:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 05:42:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:48:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:43:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 12:30:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 11:55:45 PM
- BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics M • PR Newswire (US) • 03/12/2026 01:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2026 07:23:14 PM
- U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU) • PR Newswire (US) • 02/28/2026 01:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 01:49:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 01:39:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 01:31:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 01:28:58 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 06:59:04 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 05:30:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 03:18:05 PM
- BioMarin to Participate in Four Upcoming Investor Conferences in March • PR Newswire (US) • 02/24/2026 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 09:08:42 PM
